高级检索
    马军, 吴穗晶, 杜欣. 首次缓解后使用小剂量IL-2免疫治疗不能改善≥60岁老年急性髓性白血病患者预后[J]. 循证医学, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
    引用本文: 马军, 吴穗晶, 杜欣. 首次缓解后使用小剂量IL-2免疫治疗不能改善≥60岁老年急性髓性白血病患者预后[J]. 循证医学, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
    shu
    MA Jun, WU Sui-jing, DU Xin. Low-Dose lnterleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older with Acute Myeloid Leukemia in First Complete Remission[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
    Citation: MA Jun, WU Sui-jing, DU Xin. Low-Dose lnterleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older with Acute Myeloid Leukemia in First Complete Remission[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
    shu

    首次缓解后使用小剂量IL-2免疫治疗不能改善≥60岁老年急性髓性白血病患者预后

    Low-Dose lnterleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older with Acute Myeloid Leukemia in First Complete Remission

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回